In keeping with an expanding body of evidence that adiponectin (79) and AdipoRon (23, 64, 80) ameliorate insulin resistance and glucose intolerance via AdipoR activation, we investigated the ability AdipoRonPEG5 to recapitulate these effects and provide significant metabolic improvements. The gene discussed is ADIPOQ; the disease is Glucose intolerance.